{"id": "1337780753862696965", "creation": 1607786761.0, "user_id": "1207759186131652608", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": ".@Sanofi and @GSK have confirmed a delay in their adjuvanted recombinant protein-based #COVID19 #Vaccine owing to an inadequate immune response in older adults in a Phase 1/2 trial.\n\nhttps://t.co/qkXu0vRVPd\n\n#Pulmonary #Pathology #ClinicalTrials #LifeSciences  #GSK #Sanofi", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#PULMONARY", "#PATHOLOGY", "#CLINICALTRIALS", "#LIFESCIENCES", "#GSK", "#SANOFI"]}